Patent ID: 11896564
Assignee: PHARMACYL AB
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for the treatment of a disease resulting from pathologic inflammation, comprising administering a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof; wherein
R1 is selected from C1-C6 alkyl and C3-C6 cycloalkyl;
R2 is selected from H and C1-C3 alkyl;
R3, R4, R5, and R6 are independently selected from hydrogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 alkylthio, and halogen, wherein any alkyl is optionally substituted with one or more fluoro;
R7 is selected from hydrogen and C1-C3 alkyl; and
R8 and R9 are independently selected from C1-C6 alkyl;
wherein the treatment also includes administration of a 5-ASA agent selected from mesalazine, sulfasalazine, olsalazine, and balsalazide or a pharmaceutically acceptable salt or solvate thereof.